...
search icon
clym-img

Climb Bio Inc Share Price

CLYM
NMQ
$5.67
+$0.4
(7.59%)
1D
Industry: Biotechnology Sector: Health Care

Climb Bio Inc Analyst Forecast

Climb Bio Inc Share Price Chart

Climb Bio Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$359.33M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.05M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.15
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.05 L
$5.86 H
$5.67

About Climb Bio Inc, Common Stock

Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug IV for the treatment of primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN). The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts. more

Industry: BiotechnologySector: Health Care

Climb Bio Inc Stock Returns

Time FrameCLYMSectorS&P500
1-Week Return4.23%-1.08%-1.38%
1-Month Return37.29%-0.47%-1.81%
3-Month Return203.21%2.13%1.38%
6-Month Return247.85%17.04%5.68%
1-Year Return256.6%6.56%11.74%
3-Year Return102.21%16.78%65.15%
5-Year Return-64.34%34.34%73.68%

Climb Bio Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses20.93M35.67M45.13M40.27M82.02M[{"date":"2020-12-31","value":25.51,"profit":true},{"date":"2021-12-31","value":43.49,"profit":true},{"date":"2022-12-31","value":55.03,"profit":true},{"date":"2023-12-31","value":49.1,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(20.93M)(35.67M)(45.13M)(40.27M)(82.02M)[{"date":"2020-12-31","value":-2092500000,"profit":false},{"date":"2021-12-31","value":-3567200000,"profit":false},{"date":"2022-12-31","value":-4513500000,"profit":false},{"date":"2023-12-31","value":-4027500000,"profit":false},{"date":"2024-12-31","value":-8202000000,"profit":false}]
Total Non-Operating Income/Expense--1.27M9.78M16.25M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":7.79,"profit":true},{"date":"2023-12-31","value":60.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(20.67M)(47.48M)(45.24M)(35.12M)(73.90M)[{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false},{"date":"2024-12-31","value":-7389700000,"profit":false}]
Income Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(20.67M)(47.48M)(45.24M)(35.12M)(73.90M)[{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false},{"date":"2024-12-31","value":-7389700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(20.67M)(47.48M)(45.24M)(35.12M)(73.90M)[{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false},{"date":"2024-12-31","value":-7389700000,"profit":false}]
EPS (Diluted)-(1.12)(1.72)(1.31)(2.13)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-112,"profit":false},{"date":"2022-12-31","value":-172,"profit":false},{"date":"2023-12-31","value":-131.25,"profit":false},{"date":"2024-12-31","value":-213.14,"profit":false}]

Climb Bio Inc Ratios

Climb Bio Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

CLYM
Cash Ratio 17.56
Current Ratio 18.38

Climb Bio Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CLYM
ROA (LTM) -17.35%
ROE (LTM) -25.65%

Climb Bio Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CLYM
Debt Ratio Lower is generally better. Negative is bad. 0.03
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.97

Climb Bio Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CLYM
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 2.03
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.58

FAQs

What is Climb Bio Inc share price today?

Climb Bio Inc (CLYM) share price today is $5.67

Can Indians buy Climb Bio Inc shares?

Yes, Indians can buy shares of Climb Bio Inc (CLYM) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLYM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Climb Bio Inc be purchased?

Yes, you can purchase fractional shares of Climb Bio Inc (CLYM) via the Vested app. You can start investing in Climb Bio Inc (CLYM) with a minimum investment of $1.

How to invest in Climb Bio Inc shares from India?

You can invest in shares of Climb Bio Inc (CLYM) via Vested in three simple steps:

  • Click on Sign Up or Invest in CLYM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Climb Bio Inc shares
What is Climb Bio Inc 52-week high and low stock price?

The 52-week high price of Climb Bio Inc (CLYM) is $5.86. The 52-week low price of Climb Bio Inc (CLYM) is $1.05.

What is Climb Bio Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Climb Bio Inc (CLYM) is

What is Climb Bio Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Climb Bio Inc (CLYM) is 2.03

What is Climb Bio Inc dividend yield?

The dividend yield of Climb Bio Inc (CLYM) is 0.00%

What is the Market Cap of Climb Bio Inc?

The market capitalization of Climb Bio Inc (CLYM) is $359.33M

What is Climb Bio Inc's stock symbol?

The stock symbol (or ticker) of Climb Bio Inc is CLYM

How Can Investors Use Climb Bio Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Climb Bio Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Climb Bio Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Climb Bio Inc shares for Indian investors?

When investing in Climb Bio Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Climb Bio Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Climb Bio Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Climb Bio Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Climb Bio Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top